chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer and described the occurrence of tingling over body in a 67-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medications included LIPITOR and SYNTHROID. On 17 August 2009 at 14:00 the subject received 1st dose of HAVRIX (unknown). On 1 September 2009, 15 days after vaccination with HAVRIX, the subject experienced tingling over body. At the time of reporting, the tingling over body was unresolved. The consumer (the subject) reported that approximately two weeks after receiving a HAVRIX injection he experienced body tingling. The subject noted that the tingling was primarily in his arms and legs. The subject reported that he had consulted with a healthcare professional concerning the tingling over his body. At the time of reporting, the subject had not received the second dose of HAVARIX in the series.
Patient started with fever and maculopapular rash to face on 3/6/21. Fever resolved 3/7/21. Rash spread to neck, trunk and proximal thighs over 48 hrs and then stabilized.
I just wanted to let you know that after my vaccine on 8/24/20 I did have several side effects. I felt okay all day, other than pain at the injection site, but then went I went to bed I had a lot of difficulty sleeping that night. I had shivering and unusual muscle pain throughout my body, a slight fever (although I didn't take my temperature). I did take Tylenol several times in about 36 hours. I also had an unsettled stomach and my heart seemed to be beating faster than normal. I was extremely tired until early afternoon the next day.
Vertigo; Severe dizziness; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 06Apr2021 at 02:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included no other health issues. The patient had no known allergies to food, medications or other products. Concomitant medications included ibuprofen 200 mg (MANUFACTURER UNKNOWN) after second vaccination for unknown indication from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 09Mar2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 07:00 the patient experienced severe dizziness and vertigo. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events severe dizziness and vertigo was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
pt recv vax 17OCT95 & 22JAN98 pt exp varicella which was described as scattered vesiculo-papular lesion on an erythematous base;approx 15 lesions on face, scalp, neck & trunk;pt seen by MD dx w/chickenpox illness;
Pt. came in for a flu shot and mentioned he had problem with vaccination before (passed out). He was instructed to rest for 15 mins. after vaccination. Patient was unconscious with mild tremors when I checked back on him after 5 mins. 911 was called and pt. been able to regain consciousness within couple mins. and left with the EMT. Pt. was contacted 2/16/2018 and he recovered with no problem and discharged from ER 2/15/18.
Contracted COVID-19 on 01/19/2022, resolved within 3days,  dose of Remdesivir, missed 2 weeks of work then on 02/05/22 became sick again, my primary internist diagnosed me with post COVID-19 syndrome and missed another week of work.
Pt devel erythema, warmth, & tenderness @ inject site p/recvd DT (peds); the area involved was the size of a quarter; pt also exp low grade fever;
Dizzy, headache, pale, flush within 10-15 mins post-injection. Resolved, then felt sleepy.  Transferred to the hospital for eval. D/C'd home the following day in stable condition.
The pt was given HPV #2.  She c/o blurred vision, clammy and blood pressure dropped to 80/54.  Paramedics were called to the health center.  When paramedics arrived, pt was feeling better. She refused to go to the hospital.  She stayed in the health center and was monitored by the nurses until her blood pressure was 112/70.
Palpitations, Tachycardia, pt reported racing heart, irregular hearbeat, tachycardia and discomfort starting at 6pm on 11/1, lasting until approx wed 11/3 at 9pm Narrative: Pt received his Moderna booster shot (0.25ml) on 11/1/2021 at approx 7:20am. His symptoms began around 6pm the evening of 11/1. He reported feeling his heart racing, palpitations and general discomfort. He denied feeling chest pain. He reported his symptoms lasted several hours. He opted to rest and did not seek medical attention. He felt slightly improved on Tuesday (11/2)morning, but continued to feel symptoms of racing heart, palpitations and general discomfort. He stayed home from work and rested. When he woke on Wednesday, his symptoms were improved, but persisted, so he decided to Urgent Care for evaluation. Per pt report, he was assessed with an EKG. He states they did not do labs or other imaging. Reported no medications or fluids were administered. Pt reports his heart rhythm was normal, but his heart rate was slightly elevated. He was discharged home with instructions to rest, increase fluids and take ibuprofen for discomfort pain. He was give strict precautions to return for worsening symptoms. He was told his symptoms may have been myocarditis or pericarditis, but was not given a diagnosis. As of 11/5, pt reported his symptoms were mostly resolved.
Redness, swelling encompassing right upper arm measuring 110 mm painful. No papules no vesicles. Treated with cephalexin 500mg TID x 5 days.
Currently experiencing reddened area from injection site about one-half way to elbow and both to the anterior and posterior of the arm with itching.  It is gradually improving and the itching is less today.
Rt eye swelling approx 1/2 hr after flu vaccine also developed approx 2" inch redness, swelling, hot to touch on (L) arm where vaccine given.
Student started having chest pain the next day on 5/19/2021. Seen at student health on 5/21/21 for atypical chest pain. Had normal EKG. Labs drawn for D-Dimer and troponin.  Sent to ED next day when troponin came back at critical level - 7.42. He was admitted from ED to hospital 5/22/21 with myocarditis - discharged on 5/52/21 with final Dx of Non-ST elevation myocardial infarction,  Of note he has a twin who was diagnosed with myocarditis last year.
My child received the GARDASIL shots-all 3-and now has 3 plantar warts on her feet. The shots began in June 2009 thru Dec. 2009.
Employee completed 15 minute observation time after vaccination, then informed observers that she had been feeling lightheaded and had a metallic taste in her mouth since just a few minutes after her vaccination had been given.  She was advised to be seated again and did so.  She was given water but refused juice.  BP 132/80, Heart rate 60, Respiratory Rate 16 @ 1128.  At 1132, recipient stated she felt better, we requested that she continue to stay for monitoring.  At 1140, recipient said she felt fine, no longer lightheaded, but still had metallic taste in her mouth.  She was able to ambulate without issues.  Left at 1141.
pt recvd vax & exp flu-like sx, hot sensation in hands, tingling in both arms, hot flash in spine (every 3-5 days) & bilateral arm tremor;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
DAILY NAUSEA/VOMITING.  Duration from 03-06-2021 to date.
bleeding; sore throat; sickness; raw blisters; joint pain early morning; This is a spontaneous report received from a contactable consumer. This consumer (patient's mother) reported for a 37-year-old male patient in response to Non-HCP letter sent in cross referenced case that included:  A 37-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via unspecified route of administration in Arm left on 10Mar2021 at 11:13 (Batch/lot number: EN6207) and second dose administered in Arm right on 30Mar2021 at 10:45 AM (Batch/lot number: EP7533) both doses as a single dose for Covid-19 immunisation. Patient's medical history included, a traumatic brain injury on 18Jun1995 at age 11-17 years old treated (4 mo), and at the age of 37 now he has short term memory issues left side spasticity from brain injury and handicapped from an unspecified date and unknown if ongoing. Concomitant medications included ibuprofen, multiple vitamin 1day gummies, Cinnamomum spp. oil, citrus aurantium essential oil, commiphora myrrha oil, eucalyptus spp. essential oil, rosmarinus officinalis essential oil, syzygium aromaticum essential oil (DOTERRA ON GUARD), and Peppermint on guard for unknown indication. History of all previous immunization with the Pfizer vaccine considered as suspect was reported as A6E37. After vaccination, on an unspecified date in 2021, patient experienced joint pain early morning and was hardly ever sick, was shocked at severity of sore throat in evening and actually bleeding. He went to doctor next morning and they though it could be Scarlet fever. After 2 days, it was reported that the symptom does not show the actual bleedings lower back of throat not shown also raw blisters punch like marks. The patient underwent lab test which included culture results as negative on an unspecified date and strep investigation test, results as negative on 02Apr2021 (did strep test looked like scarlet fever; Had no fever). The outcome of events was unknown.
After receiving 2nd dose of Pfizer vaccine and around late summer while out walking my dog which I have done everyday, i began to experience some shortness of breath and had to stop and let the episode settle down. A few days later, this happened again. Later around mid October I experienced again shortness of breath when i climbed the stairs of my house. I had to again let the episode settle down by sitting. This became a common occurrence almost daily either walking outside or climbing the stairs so I decided that i would reach out to my PCP to seek his advise. I met with him on 1/07/2022 and he recommended that because of my symptoms that I was experiencing to get blood work done and to schedule a CT scan. I was sceduled to have this blood draw on 1/07/2022 and had fasted the night before. I woke up around 3:30 am to go to the bathroom and found it very difficult to breath even taking a few steps from my bed. I began to sweat all over and had to stop in place to let it settle down. I took another 3 steps and it started up again. I reached out to Dr and he said to go to the ER immediately and that all the tests he had ordered for me would be done including the Ct scan They foud I had blood clots in both lungs and cluster in the right leg.
Had no adverse reactions until the next day.  On Saturday 12/18 I woke up with a headache, severe body, muscle, joint pain.  Was nauseous and could not eat. Tried ginger ale took otc medicine for stomach.  Became incontinent and was unable to control urine output. Spent day in bed.  On Sunday 12/19 headache was better but body, muscle and joint pain persisted.  Incontinence stopped however I could not eat.  That night I woke up 3 times and needed to change my pajamas as they were soaking wet as well as my scalp. Day 3: 12/20 I was still achy (although on a lesser scale), had no appetite and no energy.  Spent a good part of day in bed.  Day 4 I?m starting to feel somewhat normal.
Became extremely sleepy around 5 PM. Around 8 PM, started vomiting, diarrhea, fever, chills, shakes, body aches.  Felt better by 6 AM Saturday except sleepiness and body aches. Sleepiness/achiness stopped around 4:30 PM Saturday. Injection site sore from shot until Sunday evening.
This is a 22-year-old gentleman who is a student of a local  college here who has been immunized against COVID-19 in August.  Then about 10  days ago, he had to have a COVID-19 test done because he was exposed to  somebody on his football team who had COVID-19 and he did test positive.  He  just came out of quarantine yesterday and had a long workout session for his  football team, but was not drinking enough fluid, started to have abdominal cramps  and then arms and leg cramps and therefore came to the emergency room where  his creatinine was found to be 1.6, without a baseline in our system.  Also,  his CPK was 791, which after a L of fluid actually went to 832.  The patient  says he feels a whole lot better right now and his cramps are almost resolved.   We will give him a couple more L of fluids and recheck his CPK and BMP in a  few hours and then make a decision whether the patient can be discharged from  the ER or be admitted for his possible AKI and elevated CPK.  He also has a  slight white count of 11.43, but he is denying any chest pain, shortness of  breath or cough, fever or chills. No urinary s/s..  Mild leukocytosis with a recent COVID-19 infection.  Checking chest x-ray  and urinalysis.  Patient denies any fever, chills, or cough or any urinary  symptoms.  No diarrhea either.  Given fluids and discharged on 9/17/21
patient received only the liquid diluent component of the Menveo (two vial presentation); patient received only the liquid diluent component of the Menveo (two vial presentation); This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA928A, expiry date 31-MAY-2024) for prophylaxis.   On 14-AUG-2023, the patient received Menveo. On 14-AUG-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: patient received only the liquid diluent component of the Menveo (two vial presentation)) and inappropriate dose of vaccine administered (Verbatim: patient received only the liquid diluent component of the Menveo (two vial presentation)). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 15-AUG-2023 The vaccine administration facility was the same as primary reporter. The reporter consented to follow up by email. The patient received only the liquid diluent component of the Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Pt came back to MD office today complaining of pain at injection site and swelling of the area. Has large reddened area on upper right arm. States has looked this way for 2 days. Complaining of itchy skin also. MD diagnosed today as local reaction to PREVNAR 13 vaccine.
felt lightheaded; shoulders ache; hoarse throat; tired; headache; nausea; body aches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt lightheaded), ARTHRALGIA (shoulders ache), DYSPHONIA (hoarse throat), FATIGUE (tired) and HEADACHE (headache) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (erythromycin) and Penicillin allergy.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced HEADACHE (headache), NAUSEA (nausea) and PAIN (body aches). On an unknown date, the patient experienced DIZZINESS (felt lightheaded), ARTHRALGIA (shoulders ache), DYSPHONIA (hoarse throat) and FATIGUE (tired). At the time of the report, DIZZINESS (felt lightheaded), ARTHRALGIA (shoulders ache), DYSPHONIA (hoarse throat), FATIGUE (tired), HEADACHE (headache), NAUSEA (nausea) and PAIN (body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) negative.   Action taken with mRNA-1273 in response to the events was not applicable     No concomitant medication provided no treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: FU received on 08-May-2021. Updated the alternate phone number  of the  patient
FEELS LIKE DEAF ON BOTH EARS; FEELS NUMB IN HEAD; EARS FEEL NUMB; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported,batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced feels numb in head. On APR-2021, the subject experienced ears feel numb. On 14-APR-2021, the subject experienced feels like deaf on both ears. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the feels like deaf on both ears, feels numb in head and ears feel numb was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious.
(Started 10/25/2008)  Severe itching (generalized) over entire trunk, upper/lower extremities.  10/27 itching continued to 10/30/08 (evening) Received prescription at clinic-See enclosed
High frequency ringing sound in both ears 24/7 throughout the day.   Have not consulted a physician yet.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31-year-old male patient received BNT162b2 (BNT162B2), on 18Oct2021 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 30 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Chronic fatigue syndrome following EBV" (unspecified if ongoing); "Chronic fatigue syndrome following EBV" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Apr2023, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Apr2023) Never stopped testing positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient had received Paxlovid from 22Apr2023 to 26Apr2023 as COVID-19 treatment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300175986 same reporter/patient, different drug/event;
48hr p/vax arm became red, hot swollen & itchy;area confined to 10 x 10cm area of arm;no systemic sx;resolved w/compress & PO DPH;
All over severe body aches in joints and back, headache lasting 12 hours, fever of 99.0°-101° 14+ hours, extreme fatigue
This spontaneous report as received from another health professional refers to a patient of unknown age and gender. No medical history or concurrent conditions were reported. It was reported that on 03-SEP-2013, GARDASIL went out of range as it was exposed to 31.2 F for 6 hours. On 18-SEP-2013, the patient was administered with this improperly stored GARDASIL (route of administration unknown). Lot number was reported as H021861 with an expiration date of 09-OCT-2015. No adverse effects were reported. No further information was provided. This is one of 16 reports from the same reporter. Additional information has been requested.
"I" feel tingles on "my"  right hand fingers and right leg; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 21Apr2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021 at 15:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation.  On 24Apr2021 at 08:00 the patient experienced tingles on his right hand fingers and right leg. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event  tingles on his right hand fingers and right leg was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Burning eyes, Burning Throat, Liquid going down throat.  Numbness on left side of face. 30 minutes after shot. Burning eyes and throat lasted 10 minutes. Numbness in face lasted around 12 hours.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment information provided.
2 patients have demonstrated a significant reaction (severe swelling, pain, redness, itching) at injection site after receiving  Pneumovax 23 (lot 0055R).